Navigation Links
CHF International Named Global Fund Principal Recipient in Honduras
Date:11/20/2007

SILVER SPRING, Md., Nov. 20 /PRNewswire-USNewswire/ -- CHF International has been selected as the Global Fund to Fight AIDS, Tuberculosis and Malaria's (Global Fund) new Principal Recipient (PR) for HIV/AIDS prevention, treatment and care in Honduras--the only country in Latin America awarded an HIV proposal in Round 3 programming.

As a PR, over the next six years, CHF will be directly responsible for managing Honduras' US$47 million in HIV-focused resources for the Global Fund, including program development, technical support, volunteer and community mobilization, pharmaceutical procurement and monitoring and evaluation. CHF International will directly sub-grant the Global Fund resources to the Honduran government and civil society organizations fighting the epidemic, while building their capacity to provide sustainable, high-quality services.

"After 20 continuous years of working in Honduras, we are extremely pleased to have the opportunity to help the country develop the sustainable systems and technical capacity needed for them to effectively respond to the HIV/AIDS epidemic on their own," said Randy Lyness, CHF International's Regional Director for Latin America and the Caribbean.

For five years, CHF International successfully managed the Sustainable Improvements to Family Health Program, a partnership of CHF, the U.S. Agency for International Development, the Honduras Ministry of Health and the National Water and Sewer Authority. The program provided grant funds to 43 government health program implementers to improve reproductive heath and child survival, infectious disease, health reform, and the prevention of HIV/AIDS and other sexually-transmitted infections.

Guided by CHF International's community-based approach, one of the organization's key efforts will be working at grassroots levels with community members and volunteers so that they can more effectively sustain their efforts in HIV education, prevention, treatment and
'/>"/>

SOURCE CHF International
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Even with years of experience under his belt, Kirk ... growth, participating in two recent events for his State Farm ... networking event with the leaders of State Farm and thousands ... and greatest in insurance news and products for his clients. ... (Stacy, Anthony, Reina and Jacob) as exhibitors at the recent ...
(Date:11/21/2014)... TX (PRWEB) November 21, 2014 ... facility at 7am today. The new facility is located ... open 24-7. , “We are pleased to join ... highest quality emergency medical care here,” said Dr. Siddiqi, ... , To celebrate the opening, First Choice ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. 20, 2014 ... of a still-beating heart has the potential to improve the ... new study. Heart patients who received the gel implant ... hundreds of feet farther during a six-minute walk test, said ... cardiovascular division at Washington University School of Medicine and a ...
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Kidney donation is one ... another. And now a new study finds that former donors ... benefiting from policies that give them priority on the transplant ... of the 16,900 kidney transplants that took place in the ... the study researchers. At the time of donation, ...
(Date:11/18/2014)... Hawthorne cosmetic dentist , Dr. Yashari, is now ... of Americans over the age of 35 are missing a ... are missing not just one but all of their natural ... offers a look, feel, and function that closely resembles that ... consultation that allows patients to learn more about their options. ...
Breaking Medicine News(10 mins):Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3Health News:Study Supports Giving Kidney Donors Priority When They Need a Kidney 2Health News:Hawthorne Dentist, Dr. Yashari, is Now Making Dental Implants More Affordable for Patients 2
... With seedlings and shoots still poking their leafy tops ... published research of Brown University biologist Alison DeLong without musing ... spring in spring. DeLong,s paper, published in advance online ... insights into the intricate network of proteins that controls plant ...
... 18, 2011 Illicit drug overdose deaths declined dramatically ... facility located in Vancouver, Canada, according to the findings ... Lancet. In the first peer-reviewed ... on overdose mortality, researchers observed a 35% reduction in ...
... EDITORS: Photo available at http://today.uci.edu/news/2011/04/nr_ptips_110421.php Irvine, Calif., ... will use a $3.2 million National Institutes of ... at lessening the anxiety and pain children feel ... professor and chair of anesthesiology & perioperative care, ...
... and working memory may result from an improved ability ... rhythm. This rhythm is thought to "turn down the ... value of meditation may be helping the brain deal ... (MGH), Harvard Medical School and the Massachusetts Institute of ...
... high school athlete drops dead, the rare but fatal ... reasons that remain a mystery to scientists, some young ... an unusual heart arrhythmia. With over-exertion, their hearts stop ... screening for the hard-to-detect syndrome has been prohibitively expensive. ...
... Pediatric Dermatology reveals that routine, long-term use of topical ... any significant, negative side effects. Parental phobia of TCS is ... commonest fear is that TCS use will "thin the skin." ... including pharmacists. Led by Gayle Fischer, MBBS, FACD, of The ...
Cached Medicine News:Health News:In time for spring, biologist illuminates how seedlings regulate growth 2Health News:Deaths from drug overdose decline 35 percent after the opening of supervised injection site 2Health News:UCI anesthesiologist to lead study on alleviating surgical anxiety, pain in children 2Health News:Meditation may help the brain 'turn down the volume' on distractions 2Health News:Meditation may help the brain 'turn down the volume' on distractions 3Health News:Standing up for athletes at risk 2
(Date:11/21/2014)... THE WOODLANDS, Texas , Nov. 21, 2014 /PRNewswire/ ... announced the pricing of its previously announced underwritten public ... pursuant to an effective shelf registration statement. The offering ... a public offering price of $1.005 per share.  Lexicon ... purchase up to 7,462,687 additional shares of common stock.  ...
(Date:11/18/2014)... LOS ANGELES , Nov. 18, 2014 /PRNewswire/ ... technology development, patient engagement and study recruitment – ... platform, called Sangre, to help Pfizer Inc. find ... Pain (CIP) and their family members to participate ... help potentially identify DNA mutations and hopefully aid ...
(Date:11/18/2014)... 18, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... manuscript on Risk-Based Monitoring (RBM), " Evaluating ... Measure in Clinical Trials ," in the ... Regulatory Science  (TIRS) journal. Developed by TransCelerate,s ... the manuscript examines the value of Source ...
Breaking Medicine Technology:Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3
... to 3D Composer Series -- MATUYAMA-CITY, Japan, Sept. 24 ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to... -- ARDEE, Ireland, Sept. 24 ... ... --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Medicine Technology:3D FS-Composer Added to 3D Composer Series 23D FS-Composer Added to 3D Composer Series 33D FS-Composer Added to 3D Composer Series 43D FS-Composer Added to 3D Composer Series 53D FS-Composer Added to 3D Composer Series 6Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 2Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 3Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 4Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 5Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 6Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 7Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 8Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash 9
IDS Rapid One, a microbial identification system....
IDS Rapid NF Plus, a microbial identification system....
Versatrek 240 is versatile as four tests can be performed on one platform such as blood culture, sterile body fluids, mycobacteria and mycobacteria susceptibility testing. This model comes equipped w...
BD Phoenix is an automated microbiology system used for identification and susceptibility testing....
Medicine Products: